poziotinib drug development hanmi pharmaceutical south korea luye pharma china spectrum pharmaceuticals rest world various built anilinoquinazoline scaffold inhibits epidermal growth factor receptors egfr binds covalently discovered hanmi august hanmi exclusively licensed rights china chinese company luye pharma february hanmi licensed rights rest world outside south korea spectrum started phase ii trial poziotinib secondline treatment breast httpsenwikipediaorgwikipoziotinib